AtriCure (NASDAQ-ATRC) Stock Price Today • Wrapstocks

$23.16

24H

1.96%

Market Cap

1.1 B

Volume

761.3 K

Supply

48.4 M

Price Chart

About AtriCure - ATRC

AtriCure, Inc. is a medical device company that provides innovative solutions designed to decrease the global Afib epidemic, primarily focused on developing, manufacturing, and selling devices to treat atrial fibrillation and related conditions. Their product line includes a variety of minimally invasive ablation devices and access tools to facilitate cardiac tissue ablation procedures.

AtriCure, Inc.'s mission is to provide innovative electrosurgery tools to improve the quality of life and health of patients with atrial fibrillation. Their core values focus on innovation, teamwork, accountability, and a commitment to patients which drives their pursuit of excellence in developing surgical treatments for atrial fibrillation and related conditions.

AtriCure, Inc. was founded by Dr. Elizabeth D. Krell and Dr. Alan Mark Able in 2000.

As of the latest available information before your specified restrictions, Michael Carrel is the President and CEO of AtriCure, Inc. However, for the most current leadership information, please refer to the company's official communications or website.

AtriCure, Inc. is headquartered in Mason, Ohio, and its base country is the United States.

AtriCure, Inc. is traded on the NASDAQ stock exchange under the ticker symbol ATRC.

AtriCure (ATRC) Price Live Data

The live price of AtriCure (ATRC) is $23.16, with a trading volume of 761,310 in the last 24 hours. Wrapstocks updates the ATRC price in real-time. AtriCure is up 1.96% in the last 24 hours. The company has a live market cap of $1,120,113,920.00 and a supply of 48,374,602 ATRC stocks.

AtriCure (ATRC) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 4 hours and 24 minutes.

NASDAQ

NASDAQ Stock Exchange

Opens in

4 hours and 24 minutes

Working Hours

Mon-Fri, 01:30 PM - 08:00 PM

Timezone

GMT+0